A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
- PMID: 30369600
- PMCID: PMC6251033
- DOI: 10.1038/s41416-018-0303-7
A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
Abstract
Background: We modified and evaluated an advance care planning (ACP) intervention, which had been shown to improve compliance with patient's end of life (EoL) wishes, in a different patient population.
Methods: Patients with incurable cancer, and a Family Member (FM), were randomised one-to-one to usual care or usual care plus an ACP intervention, between April 2014 and January 2017. Oncologists and participants were non-blinded. ACP was based on the Respecting Patient Choices model, with an offer to provide individualised ranges for typical, best-case and worst-case scenarios for survival time. Seven facilitators (two oncology nurses, two nurses and three allied health professionals) delivered the intervention within 2 weeks of study enrolment. The primary outcome measure, assessed by interviewing the FM 3 months after patient death, was the FM perception that the patient's wishes were discussed, and met.
Results: Six hundred and sixty-five patients from seven Australian metropolitan oncology centres were referred for consideration by their oncologists, 444 (67%) met the study inclusion criteria and were approached by a study researcher. Two hundred and eight patients (47%) and their FM entered the trial as dyads. Fifty-three (46%) dyads in the ACP group and 63 (54%) dyads in the usual-care group had complete primary outcome data (p = 0.16). Seventy-nine patients and 53 FMs attended an ACP discussion. Mean length of discussion was 57 min. FMs from 23 (43%) dyads allocated to ACP and 21 (33%) dyads allocated usual care reported the patient's EoL wishes were discussed and met (difference 10%, 95% CI: -2 to 8, p = 0.27). There were no differences in EoL care received, patient satisfaction with care; FM satisfaction with care or with death; or FM well being. Rates of palliative care referral were high in both groups (97% vs 96%).
Conclusions: A formal ACP intervention did not increase the likelihood that EoL care was consistent with patients' preferences.
Conflict of interest statement
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. B.E.K. reported receiving personal fees from Roche and Novartis for lectures and advisory board membership, as well as non-financial support from Amgen, for work outside of the submitted work.
Similar articles
-
Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial.BMJ Open. 2016 Dec 1;6(12):e012387. doi: 10.1136/bmjopen-2016-012387. BMJ Open. 2016. PMID: 27909034 Free PMC article. Clinical Trial.
-
Advance care planning in patients with advanced cancer: A 6-country, cluster-randomised clinical trial.PLoS Med. 2020 Nov 13;17(11):e1003422. doi: 10.1371/journal.pmed.1003422. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33186365 Free PMC article. Clinical Trial.
-
A qualitative analysis of responses to a question prompt list and prognosis and end-of-life care discussion prompts delivered in a communication support program.Psychooncology. 2015 Mar;24(3):287-93. doi: 10.1002/pon.3635. Epub 2014 Jul 30. Psychooncology. 2015. PMID: 25079976
-
Interventions Guiding Advance Care Planning Conversations: A Systematic Review.J Am Med Dir Assoc. 2019 Mar;20(3):227-248. doi: 10.1016/j.jamda.2018.09.014. Epub 2018 Nov 22. J Am Med Dir Assoc. 2019. PMID: 30471947
-
Impact of advance care planning and end-of-life conversations on patients with cancer: An integrative review of literature.J Nurs Scholarsh. 2023 Jan;55(1):272-290. doi: 10.1111/jnu.12804. Epub 2022 Aug 10. J Nurs Scholarsh. 2023. PMID: 35946931 Review.
Cited by
-
Effect of FAmily CEntered (FACE®) Advance Care Planning on Longitudinal Congruence in End-of-Life Treatment Preferences: A Randomized Clinical Trial.AIDS Behav. 2020 Dec;24(12):3359-3375. doi: 10.1007/s10461-020-02909-y. AIDS Behav. 2020. PMID: 32399799 Free PMC article. Clinical Trial.
-
We Need a Paradigm Shift Around End-of-Life Decision Making.J Am Geriatr Soc. 2021 Feb;69(2):327-329. doi: 10.1111/jgs.16899. Epub 2020 Nov 10. J Am Geriatr Soc. 2021. PMID: 33170951 Free PMC article. No abstract available.
-
Voluntary assisted dying: estimating life expectancy to determine eligibility.Med J Aust. 2022 Aug 15;217(4):178-179. doi: 10.5694/mja2.51648. Epub 2022 Jul 24. Med J Aust. 2022. PMID: 35871393 Free PMC article. No abstract available.
-
How to Intervene in the Health Management of the Oncological Patient and of Their Caregiver? A Narrative Review in the Psycho-Oncology Field.Behav Sci (Basel). 2021 Jul 9;11(7):99. doi: 10.3390/bs11070099. Behav Sci (Basel). 2021. PMID: 34356716 Free PMC article. Review.
-
Understanding of Health-related Decision-making Terminology Among Cancer Caregivers.West J Nurs Res. 2021 Jul;43(7):649-659. doi: 10.1177/0193945920965238. Epub 2020 Oct 16. West J Nurs Res. 2021. PMID: 33063642 Free PMC article.
References
-
- Razmaria AA. Chemotherapy use, performance status, and quality of life at the end of life. JAMA. 2015;314:1879.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous